The U.S. Centers for Disease Control and Prevention (CDC) intends to award a sole-source contract to Illumina, Inc., a crucial supplier of test kits for DNA sequencing and library preparation. The procurement aims to ensure continuity in influenza research and public health laboratories, as these kits are compatible only with Illumina's sequencing instruments. The CDC requires these specialized kits for essential tasks in analyzing and comparing influenza data, which plays a significant role in determining the annual influenza vaccine composition. Interested parties should contact Jennifer Gartzke for more information.